The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
A Novel Method of 18F Radiolabeling for PET
Open accessAbstract
UNLABELLED: Small biomolecules are typically radiolabeled with (18)F by binding it to a carbon atom, a process that usually is designed uniquely for each new molecule and requires several steps and hours to produce. We report a facile method wherein (18)F is first attached to aluminum as Al(18)F, which is then bound to a chelate attached to a peptide, forming a stable Al(18)F-chelate-peptide complex in an efficient 1-pot process. METHODS: For proof of principle, this method was applied to a peptide suitable for use in a bispecific antibody pretargeting method. A solution of AlCl(3).6H(2)O in a pH 4.0 sodium-acetate buffer was mixed with an aqueous solution of (18)F to form the Al(18)F complex. This was added to a solution of IMP 449 (NOTA-p-Bn-CS-d-Ala-d-Lys(HSG)-d-Tyr-d-Lys(HSG)-NH(2)) (NOTA-p-Bn-CS is made from S-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid; HSG is histamine-succinyl-glycine) and heated to 100 degrees C for 15 min. In vitro and in vivo stability and targeting ability of the Al(18)F-IMP 449 were examined in nude mice bearing LS174T human colonic tumors pretargeted with an anti-CEACAM5 bispecific antibody (TF2). RESULTS: The radiolabeled peptide was produced in 5%-20% yield with an estimated specific activity of 18,500-48,100 GBq (500-1,300 Ci)/mmol. The Al(18)F-IMP 449 was stable for 4 h in serum in vitro, and in animals, activity isolated in the urine 30 min after injection was bound to the peptide. Nonchelated Al(18)F had higher tissue uptake, particularly in the bones, than the chelated Al(18)F-IMP 449, which cleared rapidly from the body by urinary excretion. Tumor uptake was 30-fold higher with TF2-pretargeted Al(18)F-IMP 449 than with the peptide alone. Dynamic PET showed tumor localization within 30 min and rapid and thorough clearance from the body. CONCLUSION: The ability to bind highly stable Al(18)F to metal-binding ligands is a promising new labeling method that should be applicable to a diverse array of molecules for PET.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamacher, K., Coenen, H. H., & Stöcklin, G. (1986) · PubMed · Cited by 1,351
Recommendations on the Use of 18F-FDG PET in Oncology
Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., Coleman, R. E., Wahl, R., Paschold, J. C., Avril, N., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047787 · Cited by 1,101
Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
Goldenberg, D. M., Sharkey, R. M., Paganelli, G., Barbet, J., & Chatal, J.-F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8471 · Cited by 351
Self-citationPoethko, T., Schottelius, M., Thumshirn, G., Hersel, U., Herz, M., Henriksen, G., Kessler, H., Schwaiger, M., & Wester, H. (2004) · PubMed · Cited by 227
Rossi, E. A., Goldenberg, D. M., Cardillo, T. M., McBride, W. J., Sharkey, R. M., & Chang, C.-H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600982103 · Cited by 209 · cited 3×
“The BsmAb was more than 95% immunoreactive against CEACAM5 and the divalent-HSG NOTA-peptide, IMP 449, using a SE-HPLC method described previously (28).”
BackgroundMethodResultSelf-citationWester, H.-J., Hamacher, K., & Stöcklin, G. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00017-0 · Cited by 200
T he B iochemistry and P hysiology of M etallic F luoride: A ction, M echanism, and I mplications
Li, L. (2003) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130301400204 · Cited by 153
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody
Sharkey, R. M., Cardillo, T. M., Rossi, E. A., Chang, C., Karacay, H., McBride, W. J., Hansen, H. J., Horak, I. D., & Goldenberg, D. M. (2005) · Nature Medicine · doi:10.1038/nm1322 · Cited by 148
Self-citationLi, Z., Wu, Z., Chen, K., Chin, F. T., & Chen, X. S. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700226v · Cited by 146
Functional Imaging of Cancer with Emphasis on Molecular Techniques
Torigian, D. A., Huang, S., Houseni, M., & Alavi, A. A. (2007) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.4.206 · Cited by 143
Ternary complexes of Al3+ and F− with a third ligand
Martin, R. B. (1996) · Coordination Chemistry Reviews · doi:10.1016/0010-8545(95)01170-6 · Cited by 122
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.
McBride, W. J., ZANZONICO, P. B., Sharkey, R. M., Norén, C., Karacay, H., Rossi, E. A., Losman, M. J., Brard, P.-Y., Chang, C., Larson, S. M., et al. (2006) · PubMed · Cited by 111
Self-citationTernary hydroxide complexes in neutral solutions of A13+ and F−
Martin, R. B. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81266-x · Cited by 99
Antonny, B., & Chabre, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50484-7 · Cited by 97
Fluoroacylation agents based on small n.c.a. [18F]fluorocarboxylic acids
Guhlke, S., Coenen, H. H., & Stöcklin, G. (1994) · Applied Radiation and Isotopes · doi:10.1016/0969-8043(94)90252-6 · Cited by 84
Sharkey, R. M., Karacay, H., Litwin, S., Rossi, E. A., McBride, W. J., Chang, C.-H., & Goldenberg, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0037 · Cited by 75
Self-citationA Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
Gold, D. V., Goldenberg, D. M., Karacay, H., Rossi, E. A., Chang, C., Cardillo, T. M., McBride, W. J., & Sharkey, R. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0232 · Cited by 74
Self-citationSharkey, R. M., Karacay, H., Vallabhajosula, S., McBride, W. J., Rossi, E. A., Chang, C., Goldsmith, S. J., & Goldenberg, D. M. (2008) · Radiology · doi:10.1148/radiol.2462070229 · Cited by 56
Self-citation
Cited by
Applications of Fluorine in Medicinal Chemistry
Gillis, E. P., Eastman, K. J., Hill, M. D., Donnelly, D. J., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00258 · Cited by 3,618
Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes
Jacobson, O., Kiesewetter, D. O., & Chen, X. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500475e · Cited by 503
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Giesel, F. L., Adeberg, S., Syed, M., Lindner, T., Jiménez-Franco, L. D., Mavriopoulou, E., Staudinger, F., Tonndorf-Martini, E., Regnery, S., Rieken, S., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.245084 · Cited by 302
Bispecific antibodies and their applications
Fan, G., Wang, Z., Hao, M., & Li, J. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0227-0 · Cited by 288
Metadata
- Authors
- McBride, W. J., Sharkey, R. M., Karacay, H., D'Souza, C. A., Rossi, E. A., Laverman, P., Chang, C.-H., Boerman, O. C., & Goldenberg, D. M.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2009-05-14
- Volume
- 50
- Issue
- 6
- Pages
- 991-998
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2032643964
- Cited by
- 418
- References
- 18
- FWCI
- 17.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.